Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025

Core Viewpoint - Exagen Inc. is set to release its financial results for Q1 2025 on May 5, 2025, with a conference call scheduled for the same day to discuss the results [1]. Company Overview - Exagen Inc. is a leading provider of autoimmune diagnostics, focused on improving care for patients with chronic autoimmune conditions [4]. - The company's flagship product, AVISE CTD, aids clinicians in diagnosing complex autoimmune diseases such as lupus and rheumatoid arthritis with greater accuracy [4]. - Exagen's laboratory specializes in testing for rheumatic diseases, offering a comprehensive suite of AVISE-branded tests for diagnosis, prognosis, and monitoring [4]. - The company emphasizes research, innovation, education, and patient-centered care in addressing challenges in autoimmune disease management [4].